<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Netvouz - link info</title>
<link>http://netvouz.com/url/8d2a9c8b45ca0897b7ccd7fa72185859?feed=rss</link>
<description>Info about a link</description>
<item><title>First Patients Undergo Surgery In Northwest Biotherapeutics&#39; Phase II Brain Cancer Trial</title>
<link>http://www.medicalnewstoday.com/articles/62996.php</link>
<description>Visitor Ratings:Healthcare Professional:not yet ratedGeneral Public:                 not yet rated&gt;&gt; rate this articleNorthwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB), a biotechnology company focused on cancer immunotherapy, today announced t</description>
<category domain="http://netvouz.com/frishawilkes?category=1633902442165728116"></category>
<author>frishawilkes</author>
<pubDate>Tue, 11 Dec 2007 00:08:25 GMT</pubDate>
</item><item><title>First Patients Undergo Surgery In Northwest Biotherapeutics&#39; Phase II Brain Cancer Trial</title>
<link>http://www.medicalnewstoday.com/articles/62996.php</link>
<description>Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBT.OB), a biotechnology company focused on cancer immunotherapy, today announced that the first two patients in its pivotal Phase II clinical trial have undergone surgery for newly diagnosed Glioblast</description>
<category domain="http://netvouz.com/scottjackson?category=7757328748682826959"></category>
<author>scottjackson</author>
<pubDate>Sat, 08 Dec 2007 03:50:51 GMT</pubDate>
</item></channel></rss>